#alhemo — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #alhemo, aggregated by home.social.
-
Concizumab (Alhemo) for Hemophilia A or B with Inhibitors
Concizumab (commercial name, Alhemo), a monoclonal antibody was approved bythe FDA on 20 December 2024 for prevention of bleeding episodes in...........
#Alhemo #Concizumab #FDA #HemophiaB #Hemophilia #HemophiliaA
SCIEU Team